EU Medical Device Regulation: Your Questions Answered, New Webinar Hosted by Xtalks
TORONTO (PRWEB) February 20, 2019 -- The EU MDR has medical device manufacturers wondering:
- Is it possible to avoid compliance with the MDR?
- When should I be compliant?
- How will this affect my new product development?
- How does this affect my products currently on the market?
- Which notified body should I use?
- How will Brexit affect my company?
- Where do I begin?
Join Premier Research experts – Nach Davé, RPh, MS, Vice President of Development Strategy and John Pappan, MA, MS, Director of Regulatory Affairs, Medical Device & Business Strategy – in a live webinar on Tuesday, March 12, 2019 at 11am EDT (3pm GMT) to get the answers you want.
This webinar will help pave the way to strategic planning for compliance with the EU MDR. New product development teams will discover that the timeline for MDR is extremely limited compared to existing products on the market. Post-market surveillance teams will discover the implications of the Post-Market Clinical Follow-up requirement and the European Database on Medical Devices.
For more information or to register for this event, visit EU Medical Device Regulation: Your Questions Answered.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Candice Tang, Xtalks, http://www.xtalks.com, 4169776555, [email protected]
Share this article